CytomX Therapeutics, Inc. Gains 40.78%

Fri, Jan 06, 2023 at 07:02 PM
CytomX Therapeutics, Inc. Gains 40.78%

CytomX Therapeutics, Inc. (CTMX:NASDAQ) rocketted at $2.52, a gain of 40.8%. On Fri, Jan 06, 2023, CTMX:NASDAQ hit a New 2-Week High of $2.52. The stock appeared on our News Catalysts scanner on Fri, Jan 06, 2023 at 03:59 PM in the 'PATNERSHIP' category. From Fri, Dec 23, 2022, the stock recorded 87.50% Up Days and 55.56% Green Days

About CytomX Therapeutics, Inc. (CTMX:NASDAQ)

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.